Cytek Biosciences, Inc. (CTKB) NASDAQ
4.19
-0.05(-1.18%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.19
-0.05(-1.18%)
Currency In USD
| Previous Close | 4.24 |
| Open | 4.18 |
| Day High | 4.28 |
| Day Low | 4.08 |
| 52-Week High | 6.18 |
| 52-Week Low | 2.76 |
| Volume | 796,729 |
| Average Volume | 801,349 |
| Market Cap | 541.11M |
| PE | -7.22 |
| EPS | -0.58 |
| Moving Average 50 Days | 4.36 |
| Moving Average 200 Days | 4.48 |
| Change | -0.05 |
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact
GlobeNewswire Inc.
Mar 09, 2026 9:00 PM GMT
Anniversary Milestone Highlights Expanded Manufacturing Capacity, Stronger Asia-Pacific Presence, and Measurable Contributions to Global Supply Chain Resilience Cytek Singapore facility Cytek Biosciences marks the one-year anniversary of its Singap
Cytek Biosciences to participate at the TD Cowen 46th Annual Health Care Conference
GlobeNewswire Inc.
Feb 18, 2026 9:05 PM GMT
FREMONT, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming TD Cowen 46th Annual Health Care Conference in B
Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
GlobeNewswire Inc.
Feb 12, 2026 9:05 PM GMT
FREMONT, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the fourth quarter and full year 2025 after market close on Thursday, F